Remodeling a Rheumatology Practice to Facilitate Early Referral
In the next 12 months, 7500 Canadians and 75,000 Americans will be afflicted with the onset of rheumatoid arthritis. Little is known about the health care use of patients with early RA. Nonetheless, rheumatologists and outcomes researchers strongly endorse the need for early diagnosis and treatment of this population. This article reviews trends and impediments to early referral of new-onset arthritis patients. The slow growth of early arthritis clinics is summarized in a survey that characterizes 23 early arthritis programs in North America. Also, several screening tools and models to capture these early-onset arthritis patients are presented.
Department of Rheumatology and Clinical Immunology, Presbyterian Hospital of Dallas, Dallas, TX, USA
Department of Rheumatology and Clinical Immunology, Presbyterian Hospital of Dallas, 8200 Walnut Hill Lane, Dallas, TX 75231-4496
Dr. Cush currently is an investigator for Abbott, Amgen, Genetech, and the National Institutes of Health and a consultant for Abbott, Amgen, Wyeth, Centocor, and Regeneron.